Pano Therapeutics

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.panotherapeutics.com/

Company Overview

Pano Therapeutics is a preclinical-stage biotechnology company that develops CNS-optimized biguanide small molecule drugs for the treatment of neurodevelopmental disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small molecule drugdrug discoverybiotechneurodevelopmental disordersmitochondrial dysfunctionCNS-optimizedbiguanidepreclinical biotechdrug licensingFragile X Syndromedrug pipelinemedicinal chemistrypharma R&Dtherapeutic developmentCNS drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pano Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Pano Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pano Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Pano Therapeutics Investors

Notable investors and investment history

Pano Therapeutics investors
Investor	Rounds
Baszucki Group	Seed
Longevitytech.fund	Seed
Western Technology Investment	Seed

View all Investors

Pano Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pano Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pano Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Year Founded2017

Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.